Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
11/29/2001 | WO2001000785A3 Regeneration of cotton plants |
11/29/2001 | WO2000075350A3 Nucleic acid sequences encoding proteins involved in fatty acid beta-oxidation and methods of use |
11/29/2001 | WO2000073469A3 Protein kinases |
11/29/2001 | WO2000070056A9 Chloramphenicol biosynthetic pathway and gene cluster characterization |
11/29/2001 | WO2000061597A9 Antiproliferative activity of g-righ oligonucleotides and method of using same to bind to nucleolin |
11/29/2001 | WO2000058489A9 Production of syringyl lignin in gymnosperms |
11/29/2001 | WO2000055340A9 Methods for enhancing the disease resistance of plants |
11/29/2001 | WO2000053229A3 Protein conjugates on the basis of lumazine synthase, methods for producing them and the use thereof |
11/29/2001 | WO2000040722A3 Insulin-synthesis genes |
11/29/2001 | US20010047526 Mapping molecular interactions in plants with protein fragments complementation assays |
11/29/2001 | US20010047525 Separating electrophoretically complexes of oligonucleotides and nuclear proteins; isolating and amplifying using primers to 5'-flanking regions; linking to a expression driving promoter operably linked to a cassette; stable cells, plants |
11/29/2001 | US20010047524 Methods and tissue culture media for inducing somatic embryogenesis, agrobacterium-mediated transformation and efficient regeneration of cacao plants |
11/29/2001 | US20010047523 Nucleic acid fragment encoding a brittle-1 homolog and construction of a chimeric gene encoding the brittle-1 homolog in sense or antisense orientation; transforming a cell to cause accumulation of sugars and starches |
11/29/2001 | US20010047522 Disease resistance in vitis |
11/29/2001 | US20010047521 Maize Rar1 polynucleotides and methods of use |
11/29/2001 | US20010047520 Parthenogenic oocyte activation |
11/29/2001 | US20010047519 Polynucleotide encoding a soluble marker protein functionally linked to a regulatory sequence of an endogenous gene encoding E-selectin; drug screening |
11/29/2001 | US20010047092 Novel plant promoters and methods of use |
11/29/2001 | US20010047091 DNA tagging with promoterless beta-glucuronidase gene generated transgenic Nicotiana tabacum plant that expressed gene activity either only in developing seed coats, or constitutively |
11/29/2001 | US20010047090 VANILREP1 polynucleotides and VANILREP1 polypeptides |
11/29/2001 | US20010047083 Produced by hybridoma cell line ATCC No. HB12003 and progeny thereof; used in detection or treatment of carcinoembryonic antigen associated tumors |
11/29/2001 | US20010047081 Adenoviral capsid containing chimeric protein IX |
11/29/2001 | US20010047080 Inhibits hiv infection of cells |
11/29/2001 | US20010047029 Diindol-3-ylphenylcarbonium and triindol-3-ylcarbonium derivatives (turbomycins); broad spectrum antibiotic and fungicidal activity |
11/29/2001 | US20010046967 Methods of preventing and treating respiratory viral infection using immunomodulatory polynucleotide |
11/29/2001 | US20010046965 Making them safer for the large-scale production of adenovirus stock for use in human gene therapy trials. |
11/29/2001 | US20010046707 Enhancing the competence of a cell through production of a library of recombinant genes |
11/29/2001 | US20010046706 Controlled electroporation and mass transfer across cell membranes |
11/29/2001 | US20010046705 Complex of nucleic acid and biodegradable cationic polyhydroxylated molecule (e.g., maltodextrin grafted with glycidyltrimethylammonium chloride); protects nucleic acid during transfection in to a cell |
11/29/2001 | US20010046704 For use in areas such as screening, production, gentic analysis, cloning, cell therapy products, etc. |
11/29/2001 | US20010046700 Fluid control module and temperature controller |
11/29/2001 | US20010046698 Method capable of increasing competency of bacterial cell transformation |
11/29/2001 | US20010046694 1-deoxy-D-xylulose-5-phosphate reductoisomerases, and methods of use |
11/29/2001 | US20010046692 Derived from Pseudomonas jessenii |
11/29/2001 | US20010046691 Enhanced production of lipids containing polyenoic fatty acid by very high density cultures of eukaryotic microbes in fermentors |
11/29/2001 | US20010046680 Identification of polypeptides and nucleic acid molecules using linkage between DNA and polypeptide |
11/29/2001 | US20010046678 Dissociating a solution of double stranded nucleic acid into single strands to measure UV absorption and acquiring a thermal melting profile |
11/29/2001 | US20010046675 Method and apparatus for producing biochips |
11/29/2001 | US20010046674 Upon binding a ligand to a signal generated by a reporter molecule, detecting and quantifying the ligand in solution |
11/29/2001 | US20010046672 Lipoxygenase proteins and nucleic acids |
11/29/2001 | US20010046670 Single stranded DNA sequence hybridizes an oligonucleotide or DNA analogue and then complexes with a marker; output signals are measured for formation and dissociation indications |
11/29/2001 | US20010046667 Determination of latent HIV infection |
11/29/2001 | US20010046499 Tick antigens and compositions and methods comprising them |
11/29/2001 | US20010046490 Cell surface molecule-induced macrophage activation |
11/29/2001 | US20010046489 Stem cells of the islets of langerhans and their use in treating diabetes mellitus |
11/29/2001 | US20010045359 Separation of cell particle by dielectrophoresis |
11/29/2001 | DE10027414A1 Peptide for gene transfer, useful e.g. in gene therapy, comprises polylysine segment with C-terminal extension, provides high transfection efficiency without receptor targeting |
11/29/2001 | DE10024740A1 Verfahren zur gesteuerten Eliminierung gewünschter DNA-Sequenzen in Wirtsorganismen A method for the controlled elimination of desired DNA sequences in host organisms |
11/29/2001 | DE10023887A1 Nucleic acid construct for transient cell transfection, useful ,e.g., in gene therapy, contains recombinase gene controlled by inducible promoter and flanking recombinase sites |
11/29/2001 | CA2808215A1 Nrg-2 nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods |
11/29/2001 | CA2704596A1 Method for examining wt1-related disease |
11/29/2001 | CA2429199A1 Drug metabolizing enzymes |
11/29/2001 | CA2413326A1 Use of baculovirus vectors in gene therapy |
11/29/2001 | CA2412306A1 Human sodium channel scn12a and scn8a |
11/29/2001 | CA2410987A1 Inhibition of smad3 to prevent fibrosis and improve wound healing |
11/29/2001 | CA2410827A1 Methods and compositions for enhancing the delivery of a nucleic acid toa cell |
11/29/2001 | CA2410536A1 Method of producing herpes simplex virus amplicons, resulting amplicons, and their use |
11/29/2001 | CA2410520A1 Mutated eukariotic translation initiation factor 2 alpha kinase 3, eif2ak3, in patients with neonatal insulin-dependent diabetes and multiple epiphyseal dysplasia (wolcott-rallison syndrome) |
11/29/2001 | CA2410337A1 Co-expression of recombinant proteins |
11/29/2001 | CA2410317A1 Methods for assaying gene imprinting and methylated cpg islands |
11/29/2001 | CA2410101A1 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
11/29/2001 | CA2410096A1 Card domain containing polypeptides, encoding nucleic acids, and methods of use |
11/29/2001 | CA2410094A1 Compositions and methods for modulating tumor specific expression |
11/29/2001 | CA2410083A1 Mammalian receptor proteins; related reagents and methods |
11/29/2001 | CA2410082A1 Dnax toll-like receptor 7 (dtlr7) protein, related reagents and methods |
11/29/2001 | CA2410081A1 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
11/29/2001 | CA2409991A1 Bispecific immunoglobulin-like antigen binding proteins and method of production |
11/29/2001 | CA2409978A1 Methods and means for enhancing skin transplantation using gene delivery vehicles having tropism for primary fibroblasts, as well as other uses thereof |
11/29/2001 | CA2409974A1 Lactobacillus reuteri glucosyltransferase |
11/29/2001 | CA2409956A1 Use of ciliary neurotrophic factor |
11/29/2001 | CA2409949A1 Short-root gene, promoter, and uses thereof |
11/29/2001 | CA2409885A1 Nucleic acid encoding a plant very long chain fatty acid biosynthetic enzyme |
11/29/2001 | CA2409881A1 Gene regulatory region that promotes root-specific transcription and its uses |
11/29/2001 | CA2409874A1 Porcine reproductive and respiratory syndrome virus (prrsv) recombinant avipoxvirus vaccine |
11/29/2001 | CA2409873A1 Hcv variants |
11/29/2001 | CA2409774A1 Methods for genetic analysis of dna to detect sequence variances |
11/29/2001 | CA2409772A1 Antiviral therapy |
11/29/2001 | CA2409309A1 Materials and methods for detection of nucleic acids |
11/29/2001 | CA2409299A1 Compositions and methods for the therapy and diagnosis of breast cancer |
11/29/2001 | CA2409236A1 Protein translocation into plant cells |
11/29/2001 | CA2409137A1 Method for microbial production of difructose anhydride iii, micro-organism used therefor and enzyme with inulase ii activity and dna sequences coding therefor |
11/29/2001 | CA2408749A1 Drug screening systems and assays |
11/29/2001 | CA2408743A1 Method of detecting inflammatory lung disorders |
11/29/2001 | CA2408739A1 Novel proteins and nucleic acids encoding same, diagnostic and therapeutic uses |
11/29/2001 | CA2408387A1 A ligand for enhancing oral and cns delivery of biological agents |
11/29/2001 | CA2408315A1 Aminoacyl trna synthetases |
11/29/2001 | CA2408302A1 Long wavelength engineered fluorescent proteins |
11/29/2001 | CA2408141A1 Neurotransmitter transporters |
11/29/2001 | CA2408140A1 G-protein coupled receptors |
11/29/2001 | CA2408125A1 Synthetic peptides and uses therefore |
11/29/2001 | CA2408022A1 Pt32 sperm protein, sperm c-yes, oocyte cytoplasmic c-yes, and uses thereof |
11/29/2001 | CA2407872A1 Receptor-based interaction trap |
11/29/2001 | CA2407570A1 Compositions and methods for delivery of a molecule into a cell |
11/29/2001 | CA2405520A1 Gene recombination and hybrid protein development |
11/29/2001 | CA2380443A1 Single-domain antigen-binding antibody fragments derived from llama antibodies |
11/29/2001 | CA2378814A1 Gene controlling shoot branching in plants |
11/28/2001 | EP1158053A1 Actinomycetes-origin cyclic plasmid dna |
11/28/2001 | EP1158052A1 Beta-primeverosidase gene |
11/28/2001 | EP1158051A1 Process for producing astaxanthin |
11/28/2001 | EP1158050A1 Human cysteinyl leukotriene receptor (CysLT2) |